Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07942207

Spanish Registry of Cardioneuroablation

Sponsor: Fundación de investigación HM

View on ClinicalTrials.gov

Summary

Spanish multicenter registry of cardioneuroablation (ablation of cardiac ganglionated plexi) in patients with reflex syncope and functional bradyarrhythmias Background Cardioneuroablation (CNA) is the catheter ablation of the ganglionated plexi (GP) of the intrinsic cardiac autonomic nervous system, located in the atrial epicardial fat, to reduce parasympathetic tone on the sinus node and the atrioventricular (AV) node. It has been proposed as an alternative to pacemaker implantation in patients, often young, with cardioinhibitory reflex syncope or vagally mediated bradyarrhythmias. However, the available evidence comes mainly from single-center series at highly experienced centers, with heterogeneous techniques (choice of atrium, number of GP targeted, localization method, type of anesthesia) and no standardized acute procedural endpoint. Data from real-world clinical practice are needed to define its efficacy and safety, and to identify which patients and which procedural strategies are associated with better outcomes. Objectives Primary: to assess syncope recurrence after CNA in real-world clinical practice in Spain. Secondary: 1) to describe the procedural characteristics and complications of CNA; 2) to identify clinical and procedural predictors of success; 3) to evaluate the change in syncope and presyncope burden and the need for pacemaker implantation during follow-up. Design Observational, multicenter, ambispective, ongoing registry with 27 participating hospitals in Spain. Cases performed since June 2018 are collected retrospectively, and prospective enrollment of consecutive patients has been in place since April 2021. Study population Inclusion criteria: consecutive patients undergoing CNA for syncope with one of the following phenotypes: * Cardioinhibitory reflex syncope: bradycardia \<40 bpm or asystole documented on tilt testing, Holter monitoring or implantable loop recorder. * Mixed reflex syncope: blood pressure drop preceding the heart rate drop on tilt testing. * Functional sinus node dysfunction. * Functional AV block. Procedure CNA is performed according to the usual practice of each center. The operator chooses: * the approach (right atrium, left atrium or both); * the number of GP targeted; * the GP localization method (anatomical, fragmented electrograms, high-frequency stimulation, extracardiac vagal stimulation or combinations); * the type of anesthesia (general anesthesia, deep sedation, conscious sedation). Data collected * Baseline: demographics, body mass index, cardiovascular history and structural heart disease, type of syncope, number of syncopal and presyncopal episodes before CNA, and diagnostic tests (tilt testing, Holter, implantable loop recorder, atropine test). * Procedural: approach, GP targeted, localization method, type of anesthesia, ablation catheter and navigation system, RF power and number of applications, procedure and fluoroscopy times, heart rate before and after CNA and response to atropine after the procedure. * Safety: procedure-related complications, including sinus node dysfunction, inappropriate sinus tachycardia and vascular complications. * Follow-up: syncope and presyncope recurrence, number of episodes per year, need for pacemaker implantation and other clinical events. Endpoints Primary endpoint: first syncope recurrence after CNA. Secondary endpoints: procedure-related complications; number of syncopal and presyncopal episodes per year before and after CNA; pacemaker implantation during follow-up. Ongoing sub-studies: 1. long-term follow-up of these patients and identification of predictors of recurrence; 2. redo procedures, in patients requiring more than one CNA; 3. patients followed with an implantable loop recorder (subcutaneous Holter). Expected relevance This registry will provide multicenter real-world data on CNA in Spain. It will help to identify the patients most likely to benefit from the procedure and the technical aspects associated with success, and will generate hypotheses for future randomized trials.

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

400

Start Date

2018-06-01

Completion Date

2031-12-31

Last Updated

2026-11-17

Healthy Volunteers

No

Interventions

PROCEDURE

cardioneuroablation

cardioneuroablation

Locations (27)

Hospital HM Monteprincipe

Madrid, Madrid, Spain

Hospital La Paz

Madrid, Madrid, Spain

Hospital Albacete

Albacete, Spain

Hospital General Alicante

Alicante, Spain

Hospital Badajoz

Badajoz, Spain

Hospital Dexeus Barcelona

Barcelona, Spain

Hospital Vall d´Hebron

Barcelona, Spain

Hospital de Basurto

Bilbao, Spain

Hospital Reina Sofia

Córdoba, Spain

Hospital Josep Trueta

Girona, Spain

Hospital Clinico Granada

Granada, Spain

Hospital Virgen de las Nieves

Granada, Spain

Hospital Juan Ramón Jiménez

Huelva, Spain

Hospital 12 de Octubre

Madrid, Spain

Hospital Fundación Jiménez Díaz

Madrid, Spain

Hospital Gregorio Marañon

Madrid, Spain

Hospital Puerta de Hierro

Madrid, Spain

Hospital Ramón y Cajal

Madrid, Spain

Hospital Torrejon

Madrid, Spain

Hospital Universitario de Navarra

Navarro, Spain

Hospital Valdecilla

Santander, Spain

Hospital Santiago de Compostela

Santiago de Compostela, Spain

Hospital La Fe

Valencia, Spain

Hospital Valladolid

Valladolid, Spain

Hospital Álvaro Cunqueiro

Vigo, Spain

Hospital Txagorritxu

Vitoria-Gasteiz, Spain

Hospital Miguel Servet

Zaragoza, Spain